Geneva Advisors’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.34M | Buy |
4,890
+24
| +0.5% | +$6.56K | 0.02% | 306 |
|
|
2017
Q1 | $1.18M | Buy |
4,866
+211
| +5% | +$51.1K | 0.02% | 317 |
|
|
2016
Q4 | $966K | Buy |
4,655
+194
| +4% | +$40.3K | 0.02% | 349 |
|
|
2016
Q3 | $1.22M | Buy |
4,461
+1,743
| +64% | +$475K | 0.02% | 278 |
|
|
2016
Q2 | $391K | Buy |
2,718
+93
| +4% | +$13.4K | 0.01% | 499 |
|
|
2016
Q1 | $377K | Buy |
2,625
+100
| +4% | +$14.4K | 0.01% | 493 |
|
|
2015
Q4 | $543K | Buy |
2,525
+587
| +30% | +$126K | 0.01% | 402 |
|
|
2015
Q3 | $314K | Hold |
1,938
| – | – | 0.01% | 474 |
|
|
2015
Q2 | $500K | Hold |
1,938
| – | – | 0.01% | 429 |
|
|
2015
Q1 | $436K | Hold |
1,938
| – | – | 0.01% | 439 |
|
|
2014
Q4 | $372K | Buy |
1,938
+168
| +9% | +$32.2K | 0.01% | 471 |
|
|
2014
Q3 | $380K | Buy |
1,770
+200
| +13% | +$42.9K | 0.01% | 472 |
|
|
2014
Q2 | $408K | Buy |
1,570
+192
| +14% | +$49.9K | 0.01% | 463 |
|
|
2014
Q1 | $300K | Hold |
1,378
| – | – | 0.01% | 480 |
|
|
2013
Q4 | $168K | Buy |
+1,378
| New | +$168K | ﹤0.01% | 475 |
|